COURSE DIRECTOR
Rabih G. Tawk, M.D.

DESCRIPTION
The Neurovascular Stroke Education Series invites consultants and trainees to an interactive discussion of neurovascular cases. Attendees are encouraged to submit cases ahead of time for review and discussion among multidisciplinary colleagues from neurology, neurosurgery, neurocritical care, and neuroradiology. Neurovascular anatomy, clinical pathology, and innovations in diagnosis and treatment will be presented as topics of discussion. This conference offers an interactive forum to present complex cases and expand the knowledge of its attendees while cultivating, an environment of collaboration among different specialties.

In-Person and Live-Streamed; Weekly on Thursdays from 7:00-8:00 p.m.

TARGET AUDIENCE
Nurses, Nurse Practitioners, Physicians, Physician Assistants, Resident Fellows, Scientist Researcher PhDs, and Students.

LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:

• Define neurovascular and functional anatomy.
• Identify appropriate management options for specific cases and disorders.
• Adopt evidence-based practice measures in neurosurgery, neurology, and neurocritical care.
• Identify areas in need for clinical improvements in cerebrovascular disorders.

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Statement(s):
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DISCLOSURE SUMMARY
As a provider accredited by Joint Accreditation for Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities.  All who are in a position to control the content are required to disclose all financial relationships with any ineligible company.   Faculty will also identify any off-label and/or investigational use of pharmaceuticals or instruments discussed in their content for FDA compliance.

Listed below are individuals with control of the content of this program who have disclosed...

Relevant Financial Relationships with Ineligible Companies:
Christopher (William) Fox, M.D.- Honoraria - MainStay Medical, Inc.; Stock Equity - Hyperion Surgical, Von Vascular
Rabih G. Tawk, M.D. - Stock Equity - Medtronic

All relevant financial relationships listed for these individuals have been mitigated.

No Relevant Financial Relationships Ineligible Companies:
Mohammed K. Badi, M.B.B.S.
Sukhwinder S. Sandhu, M.D.
Maryna Kol'Tyakova (Coordinator)
Bethany I. Wheeles (Coordinator)

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
None

2025 Speaker Pool
Relevant Financial Relationships with Ineligible Companies:
None

No Relevant Financial Relationships Ineligible Companies:

Benjamin H Eidelman, M.D.	Olga Fermo, M.D.
Stephen English JR, M.D., M.B.A.	Josephine Huang, M.D.
Young Erben, M.D.	Thien Huynh, M.D.

 

QUESTIONS?
Contact Maryna Kol'Tyakova